Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23

Trial Status

Completed3
Other1

Role Distribution

Principal Investigator2
Other Roles2
PI Rate50%

Activity Timeline

Clinical Trials (4)

NCT01761877Phase 2Completed
NSAID Effects on Clinical and Imaging Breast Biomarkers
CancerHypertensionInflammation+1 more
Principalinvestigator
NCT02613416Phase 2Completed
Denosumab and MRI Breast Imaging
Breast Cancer
Principalinvestigator
NCT04088032Early Phase 1Withdrawn
Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer
Breast Cancer FemaleHormone Receptor Positive Malignant Neoplasm of BreastLocally Advanced Breast Cancer
Studydirector

Research Network

Collaboration Network

4 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Pavani Chalasani, MD

University of Arizona

Similar
7 trials

Shared therapeutic areas:

Breast CancerPainCancer+2 more

Worked with same sponsors:

Stony Brook University
Collaborated on 1 trial
Similarity Score54%

Patricia Thompson-Carino, PhD

Stony Brook University

Moderately Similar
1 trials

Shared therapeutic areas:

CancerHypertensionInflammation+1 more

Worked with same sponsors:

Stony Brook University
Collaborated on 1 trial
Similarity Score44%

Lea Baer, MD

Stony Brook University

Moderately Similar
1 trials

Shared therapeutic areas:

Breast Cancer FemaleHormone Receptor Positive Malignant Neoplasm of BreastLocally Advanced Breast Cancer

Worked with same sponsors:

Alison StopeckAstraZeneca+1 more
Collaborated on 1 trial
Similarity Score34%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Breast CancerCancerPain
Similarity Score11%

Norman Wolmark, MD

NSABP Foundation Inc

Related
54 trials

Shared therapeutic areas:

Breast CancerPain

Worked with same sponsors:

AstraZenecaEli Lilly and Company+1 more
Similarity Score8%

Lizhi Niu, PhD

Fuda Cancer Hospital

Related
31 trials

Shared therapeutic areas:

Breast Cancer
Similarity Score4%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Cancer
Similarity Score4%

emilie garrido pradalie

APHM

Related
35 trials

Shared therapeutic areas:

Cancer
Similarity Score4%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Breast Cancer
Similarity Score4%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

Breast Cancer
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT05159778Phase 2StudyChair

Phase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2- Metastatic Breast Cancer (mBCA)

Malignant Neoplasm of Breast
Completed
NCT01761877Phase 2PrincipalInvestigator

NSAID Effects on Clinical and Imaging Breast Biomarkers

CancerHypertensionInflammation+1 more
Completed
NCT02613416Phase 2PrincipalInvestigator

Denosumab and MRI Breast Imaging

Breast Cancer
Completed
NCT04088032Early Phase 1StudyDirector

Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer

Breast Cancer FemaleHormone Receptor Positive Malignant Neoplasm of BreastLocally Advanced Breast Cancer
Withdrawn

All 4 trials loaded